Ubs Group Ag Neurocrine Biosciences Inc Call Options Transaction History

Ubs Group Ag

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 01, 2020	BUY	$75.11 - $113.76 $946,386 - $1.43 Million	12,600 Added 45.99%	40,000 $3.46 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $50,568 - $63,889	-700 Reduced 2.49%	27,400 $2.31 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $1.95 Million - $2.57 Million	28,100 New	28,100 $2.48 Million

635

93.5M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.